Preclinical Development Handbook: ADME and Biopharmaceutical Properties / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $176.03
Usually ships in 1-2 business days
(Save 20%)
Other sellers (Hardcover)
  • All (7) from $176.03   
  • New (6) from $176.03   
  • Used (1) from $181.51   

Overview

A clear, straightforward resource to guide you through preclinical drug development

Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic, comprehensive reference to prioritizing and optimizing leads, dose formulation, ADME, pharmacokinetics, modeling, and regulations. This authoritative, easy-to-use resource covers all the issues that need to be considered and provides detailed instructions for current methods and techniques.

Each chapter is written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor has carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear.

Among the key topics covered are:
*

Modeling and informatics in drug design
*

Bioanalytical chemistry
*

Absorption of drugs after oral administration
*

Transporter interactions in the ADME pathway of drugs
*

Metabolism kinetics
*

Mechanisms and consequences of drug-drug interactions

Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage.

This publication should be readily accessible to all pharmaceutical scientists involved in preclinical testing, enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.

Read More Show Less

Editorial Reviews

From the Publisher

"A valuable source of reference and one that I'm sure will get regular use. The diversity of topics should appeal to a variety of pharmaceutical scientists." (The British Toxicology Newsletter, Winter 2008)

Read More Show Less

Product Details

  • ISBN-13: 9780470248478
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 3/14/2008
  • Series: Pharmaceutical Development Series , #3
  • Edition number: 1
  • Pages: 1352
  • Product dimensions: 7.30 (w) x 10.04 (h) x 2.11 (d)

Meet the Author

SHAYNE COX GAD, PhD, DABT, ATS, is the Principal of Gad Consulting Services. Dr. Gad has more than thirty years of experience as a toxicologist, statistical consultant, manager, and general consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of thirty-four books and numerous papers, presentations, and other publications.

Read More Show Less

Table of Contents

Preface.

1 Modeling and Informatics in Drug Design (Prasad V. Bharatam, Smriti Khanna, and Sandrea M. Francis).

2 Computer Techniques: Identifying Similarities Between Small Molecules (Peter Meek, Guillermo Moyna, and Randy Zauhar).

3 Protein–Protein Interactions (Kamaljit Kaur, Dipankar Das, and Mavanur R. Suresh).

4 Method Development for Preclinical Bioanalytical Support (Masood Khan and Naidong Weng).

5 Analytical Chemistry Methods: Developments and Validation (Izet M. Kapetanovic and Alexander V. Lyubimov).

6 Chemical and Physical Characterizations of Potential New Chemical Entity (Adegoke Adeniji and Adeboye Adejare).

7 Permeability Assessment (Srinivas Ganta, Puneet Sharma, and Sanjay Garg).

8 How and Where Are Drugs Absorbed? (Marival Bermejo and Isabel Gonzalez-Alvarez).

9 Absorption of Drugs after Oral Administration (Luis Granero and Ana Polache).

10 Distribution: Movement of Drugs through the Body (Jayanth Panyam and Yogesh Patil).

11 The Blood–Brain Barrier and Its Effect on Absorption and Distribution (A. G. de Boer and P. J. Gaillard).

12 Transporter Interactions in the ADME Pathway of Drugs (Yan Zhang and Donald W. Miller).

13 Accumulation of Drugs in Tissues (Krishnamurthy Venkatesan, Deepa Bisht, and Mohammad Owais).

14 Salt and Cocrystal Form Selection (Ann W. Newman, Scott L. Childs, and Brett A. Cowans).

15 Dissolution (A.K. Tiwary, Bharti Sapra, and Subheet Jain).

16 Stability: Physical and Chemical (Eric M. Gorman, Brian E. Padden, and Eric J. Munson).

17 Dosage Formulation (Alexander V. Lyubimov).

18 Cytochrome P450 Enzymes (Eugene G. Hrycay and Stelvio M. Bandiera).

19 Metabolism Kinetics (Charles W. Locuson and Timothy S. Tracy).

20 Drug Clearance (Sree D. Panuganti and Craig K. Svensson).

21 In Vitro Metabolism in Preclinical Drug Development (Olavi Pelkonen, Ari Tolonen, Miia Turpeinen, and Jouko Uusitalo).

22 Utilization of In Vitro Cytochrome P450 Inhibition Data for Projecting Clinical Drug–Drug Interactions (Jane R. Kenny, Dermot F. McGinnity, Ken Grime, and Robert J. Riley).

23 In Vivo Metabolism in Preclinical Drug Development (Sevim Rollas).

24 In Vitro Evaluation of Metabolic Drug–Drug Interactions: Scientific Concepts and Practical Considerations (Albert P. Li).

25 Mechanisms and Consequences of Drug–Drug Interactions (Dora Farkas, Richard I. Shader, Lisa L. von Moltke, and David J. Greenblatt).

26 Species Comparison of Metabolism in Microsomes and Hepatocytes (Niels Krebsfaenger).

27 Metabolite Profi ling and Structural Identifi cation (Mehran F. Moghaddam).

28 Linkage between Toxicology of Drugs and Metabolism (Ruiwen Zhang and Elizabeth R. Rayburn).

29 Allometric Scaling (William L. Hayton and Teh-Min Hu).

30 Interrelationship between Pharmacokinetics and Metabolism (James W. Paxton).

31 Experimental Design Considerations in Pharmacokinetic Studies (William W. Hope, Vidmantas Petraitis, and Thomas J. Walsh).

32 Bioavailability and Bioequivalence Studies (Alexander V. Lyubimov and Ihor Bekersky).

33 Mass Balance Studies (Jan H. Beumer, Julie L. Eiseman, and Merrill J. Egorin).

34 Pharmacodynamics (Beom Soo Shin, Dhaval Shah, and Joseph P. Balthasar).

35 Physiologically Based Pharmacokinetic Modeling (Harvey J. Clewell III, Micaela B. Reddy, Thierry Lave, and Melvin E. Andersen).

36 Mathematical Modeling as a New Approach for Improving the Effi cacy/Toxicity Profi le of Drugs: The Thrombocytopenia Case Study (Zvia Agur, Moran Elishmereni, Yuri Kogan, Yuri Kheifetz, Irit Ziv, Meir Shoham, and Vladimir Vainstein).

37 Regulatory Requirements for INDs/FIH (First in Human) Studies (Shayne Cox Gad).

38 Data Analysis (Jayesh Vora and Pankaj B. Desai).

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)